Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis
US7641906B2 · kind B2 · utility
1Cited by
9References
25Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 27, 2005 |
| Grant date | Jan 5, 2010 |
| Priority date | — |
| Expiry date | Oct 14, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6037
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.